City of Hope | Institution Partners

Experts from City of Hope explain the importance of symptom management and care planning during cancer.

The use of FOLFOXIRI for metastatic colorectal cancer was lower than one what expert was expecting.

A recent study found a correlation between perfectionism and fear of cancer recurrence within patients with breast cancer.

The Keytruda-Lenvima combination had promising anti-tumor activity for patients with pleural mesothelioma following disease progression after chemotherapy.

After a stem cell donor saved the life of a patient with a rare leukemia, the two finally had a “very emotional” meeting this past spring in New York.

“Integrative therapies can be utilized at any point along the cancer spectrum from diagnosis, throughout treatment and into survivorship,” an expert said.

The recent FDA approval of Padcev plus Keytruda for locally advanced/metastatic, chemotherapy-ineligible bladder cancer offers an “exciting opportunity” for this difficult-to-treat patient population, an expert said.

As part of its “Speaking Out” video series, Dr. Peter Baik, on behalf of Cancer Treatment Centers of America, discussed how far the space has come with surgical advances, and where it is headed, in treating early-stage lung cancer.

As part of its “Speaking Out” video series, Dr. Peter Baik, on behalf of Cancer Treatment Centers of America, discussed the importance of timing and decision-making of treatment in early-stage lung cancer.

As part of its “Speaking Out” video series, Dr. Peter Baik, on behalf of Cancer Treatment Centers of America, discussed disparities seen in lung cancer screening and what more can be done.

There are ways to manage the fear of cancer recurrence, so it doesn’t become overwhelming or debilitating. Physicians like me and a network of resources are here to help.

One cancer survivor describes how making healthier choices in diet and exercise has improved her quality of life and relationship with others.

Head and neck cancer treatments and the subsequent side effects can be overwhelming for patients and their caregivers due to the impact they have on routine activities, writes a speech-language pathologist at Cancer Treatment Center of America Atlanta. However, the expert notes, there are plenty of specialists who can help improve patient quality of life.

Experts from Cancer Treatment Centers of America explain why mental health is important from cancer diagnosis through survivorship, the types of therapy and more.

Twenty years of updates in technology, techniques and available medications has provided more hope for patients with colorectal cancer, with more advances on the horizon.

When cancer harms the body’s ability to make antibodies, what does that mean for the efficacy of vaccines?

From the use of BTK inhibitors to maintenance therapy, an expert highlights how the treatment landscape of mantle cell lymphoma has drastically changed for the better in recent decades.

A blood cancer specialist discusses how the development of tyrosine kinase inhibitors in the 1990s to treat chronic myelogenous leukemia drove major oncology advancements over the next three decades.

When cancer treatments stop working, it is not the end of the line. Most patients with advanced disease will be on continuous therapy, and that means trying different options along the way.